|
"yen c j"的相關文件
顯示項目 386-410 / 471 (共19頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2018 |
The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma
|
Hsiao, J.-R.;Chang, Chang C.-C.;Lee, W.-T.;Huang, C.-C.;Ou, C.-Y.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2018 |
Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection
|
Yen, C.-J.;Ai, Y.-L.;Tsai, H.-W.;Chan, S.-H.;Yen, C.-S.;Cheng, K.-H.;Lee, Y.-P.;Kao, C.-W.;Wang, Y.-C.;Chen, Y.-L.;Lin, C.-H.;Liu, T.;Tsai, H.-P.;Wang, J.-R.;Su, I.-J.;Huang, W. |
| 國立成功大學 |
2018 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G.K.;Qin, S.;Ryoo, B.-Y.;Lu, S.-N.;Yen, C.-J.;Feng, Y.-H.;Lim, H.Y.;Izzo, F.;Colombo, M.;Sarker, D.;Bolondi, L.;Vaccaro, G.;Harris, W.P.;Chen, Z.;Hubner, R.A.;Meyer, T.;Sun, W.;Harding, J.J.;Hollywood, E.M.;Ma, J.;Wan, P.J.;Ly, M.;Bomalaski, J.;Johnston, A.;Lin, C.-C.;Chao, Y.;Chen, L.-T. |
| 國立成功大學 |
2018 |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Yen, C.-J.;Muro, K.;Kim, T.-W.;Kudo, M.;Shih, J.-Y.;Lee, K.-W.;Chao, Y.;Kim, S.-W.;Yamazaki, K.;Sohn, J.;Cheng, R.;Zhang, Y.;Binder, P.;Mi, G.;Orlando, M.;Chung, H.C. |
| 國立成功大學 |
2018 |
Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma
|
Lim, H.Y.;Merle, P.;Weiss, K.H.;Yau, T.;Ross, P.;Mazzaferro, V.;Blanc, J.-F.;Ma, Y.T.;Yen, C.J.;Kocsis, J.;Choo, S.P.;Sukeepaisarnjaroen, W.;Gerolami, R.;Dufour, J.-F.;Gane, E.J.;Ryoo, B.-Y.;Peck-Radosavljevic, M.;Dao, T.;Yeo, W.;Lamlertthon, W.;Thongsawat, S.;Teufel, M.;Roth, K.;Reis, D.;Childs, B.H.;Krissel, H.;Llovet, J.M. |
| 國立成功大學 |
2018 |
Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
|
Kim, T.Y.;Yen, C.-J.;Al-Batran, S.-E.;Ferry, D.;Gao, L.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 國立成功大學 |
2018 |
Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
|
Wu, S.-Y.;Lan, S.-H.;Wu, S.-R.;Chiu, Y.-C.;Lin, X.-Z.;Su, I.-J.;Tsai, Tsai T.-F.;Yen, C.-J.;Lu, T.-H.;Liang, F.-W.;Li, C.-Y.;Su, H.-J.;Su, C.-L.;Liu, H.-S. |
| 國立成功大學 |
2018 |
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study
|
Chau, I.;Park, J.O.;Ryoo, B.-Y.;Yen, C.-J.;Poon, R.;Pastorelli, D.;Blanc, J.-F.;Kudo, M.;Pfiffer, T.;Hatano, E.;Chung, H.C.;Kopeckova, Kopeckova K.;Phelip, J.-M.;Brandi, G.;Ohkawa, S.;Li, C.-P.;Okusaka, T.;Hsu, Y.;Abada, P.B.;Zhu, A.X. |
| 國立成功大學 |
2018 |
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
|
Yen, C.-J.;Kim, T.-Y.;Feng, Y.-H.;Chao, Y.;Lin, D.-Y.;Ryoo, B.-Y.;Huang, D.C.-L.;Schnell, D.;Hocke, J.;Loemb�, A.-B.;Cheng, A.-L. |
| 國立成功大學 |
2017-12-01 |
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress
|
Wu, C.-Y.;Hsu, W.-L.;Tsai, M.-H.;Liang, J.-L.;Lu, J.-H.;Yen, C.-J.;Yu, H.-S.;Noda, M.;Lu, C.-Y.;Chen, C.-H.;Yan, S.-J.;Yoshioka, T.; 顏賢章 |
| 臺大學術典藏 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Morikawa H.; Maki Y.; Tanaka T.; Ohtomo T.; Schwartz L.; Smith-Jones P.M.; Frenette C.; O’Neil B.; Shao Y.-Y.; Wan P.; Ma J.; Gansukh B.; Lyashchenko S.K.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Yen C.-J.; CHIH-HUNG HSU; Abou-Alfa G.K.; Abou-Alfa G.K.;Yen C.-J.;Chih-Hung Hsu;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Shao Y.-Y.;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Lin Z.-Z. |
| 國立成功大學 |
2017 |
Investigating the association between diet and risk of head and neck cancer in Taiwan
|
Chang, Chang C.-C.;Lee, W.-T.;Lee, Y.-C.;Huang, C.-C.;Ou, C.Y.;Lin, Y.-H.;Huang, J.-S.;Wong, T.-Y.;Chen, K.-C.;Hsiao, J.-R.;Lu, Y.-C.;Tsai, S.-T.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Yen, C.-J.;Wu, S.-Y.;Chang, J.-Y.;Fang, S.-Y.;Wu, J.-L.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2017 |
Investigating the Association between Alcohol and Risk of Head and Neck Cancer in Taiwan
|
Huang, C.-C.;Hsiao, J.-R.;Lee, W.-T.;Lee, Y.-C.;Ou, C.-Y.;Chang, Chang C.-C.;Lu, Y.-C.;Huang, J.-S.;Wong, T.-Y.;Chen, K.-C.;Tsai, S.-T.;Fang, S.-Y.;Wu, J.-L.;Wu, Y.-H.;Hsueh, W.-T.;Yen, C.-J.;Wu, S.-Y.;Chang, J.-Y.;Lin, C.-L.;Wang, Y.-H.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, G.K.;Yen, C.-J.;Hsu, C.-H.;O’Donoghue, J.;Beylergil, V.;Ruan, S.;Pandit-Taskar, N.;Gansukh, B.;Lyashchenko, S.K.;Ma, J.;Wan, P.;Shao, Y.-Y.;Lin, Z.-Z.;Frenette, C.;O’Neil, B.;Schwartz, L.;Smith-Jones, P.M.;Ohtomo, T.;Tanaka, Tanaka T.;Morikawa, H.;Maki, Y.;Ohishi, N.;Chen, Y.-C.;Agajanov, T.;Boisserie, F.;Di, Laurenzio L.;Lee, R.;Larson, S.M.;Cheng, A.-L.;Carrasquilo, J.A. |
| 國立成功大學 |
2017 |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen, W.-C.;Chen, J.-S.;Shao, Y.-Y.;Lee, K.-D.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Liao, Y.-M.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Chou, W.-C.;Hsieh, R.-K. |
| 國立成功大學 |
2016-06 |
Exposure-Response relationship of second-line ramucirumab in East Asian patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
|
Kim, T. Y.;Yen, C. -J.;Al-Batran, S. -E.;Gao, L.;Ferry, D.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 臺大學術典藏 |
2016 |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; CHENG-CHUNG FANG; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2016 |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; JENQ-WEN HUANG; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 國立成功大學 |
2015-12-01 |
Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048
|
Yen, C. J.; Klochikhin, A.; Cohen, E.; Vermorken, J.; Harrington, K.; Tahara, M.; Ge, Y.; Geib, J.; Jin, F.; Burtness, B. |
| 國立成功大學 |
2015-12-01 |
A clinical survey on satisfaction of pain management in hospitalized patients with cancer in Taiwan
|
Lin, J.; Chang, C. -S.; Lee, M. -Y.; Liao, Y. -M.; Wu, M. -F.; Sung, Y. -C.; Rau, K. -M.; Yu, M. -S.; Lai, P. -Y.; Chiou, T. -J.; Chen, J. -S.; Lee, K. -D.; Hwang, W. -L.; Liu, T. -C.; Yen, C. -J.; Shao, Y. -Y.; Hsieh, R. -K. |
| 國立成功大學 |
2015-12-01 |
Impact and predictive factor of undertreatment of analgesic drug in outpatients with cancer: a nationwide of clinical pain survey in Taiwan
|
Yang, C. -K.; Chou, W. -C.; Shen, W. -C.; Chen, J. -S.; Lee, K. -D.; Yen, C. -J.; Lai, P. -Y.; Shao, Y. -Y.; Hwang, W. -L.; Chiou, T. -J.; Sung, Y. -C.; Rau, K. -M.; Liao, Y. -M.; Chang, C. S.; Wu, M. -F.; Lee, M. -Y.; Yu, M. -S.; Liu, T. -C.; Hsieh, R. -K. |
| 國立成功大學 |
2015-09 |
Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment
|
Chau, I.; Park, J. O.; Ryoo, B. Y.; Yen, C. J.; Poon, R.; Pastorelli, D.; Blanc, J. F.; Kudo, M.; Pfiffer, T. F.; Hatano, E.; Chung, H. C.; Kubackova, K.; Phelip, J. M.; Brandi, G.; Ohkawa, S.; Li, C. P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. |
| 國立成功大學 |
2015-06-01 |
Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma
|
Palmer, D.; Meyer, T.; Chao, Y.; Deptala, A.; Fartoux, L.; Feng, Y. -H.; Graham, J.; Lin, D. -Y.; Ma, Y. T.; Peck-Radosavljevic, M.; Ross, P.; Ryoo, B. -Y.; Yen, C. -J.; Hocke, J.; Vlassak, S.; Wenz, A.; Loembe, A. -B.; Cheng, A. -L. |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國立成功大學 |
2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer
|
Lee, W-T; Huang, C-C; Chen, K-C; Wong, T-Y; Ou, C-Y; Tsai, S-T; Yen, C-J; Fang, S-Y; Lo, H-I; Wu, Y-H; Hsueh, W-T; Yang, M-W; Lin, F-C; Hsiao, J-R; Huang, J-S; Chang, J-Y; Chang, K-Y; Wu, S-Y; Lin, C-L; Wang, Y-H; Weng, Y-L; Yang, H-C; Chang, J. S. |
顯示項目 386-410 / 471 (共19頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目
|
